meclizine hydrochloride 25 MG Disintegrating Oral Tablet [Wal-Dram 2]
RxCUI 1800794
How to interpret these research links
Connected source recordsCureCurrent currently connects this RxNorm drug concept to 0 displayed clinical trials and 0 distinct registered condition labels on this page. The links show what was studied, not whether this drug is effective or approved for those conditions. FDA-label excerpts, when available, refer to specific labeled products and may include route and formulation restrictions.
Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.
What this record represents
SBD · RxNormThis is an RxNorm SBD drug concept. Its name, formulation details and source identifiers are preserved to distinguish it from other drug records.
What this record does not establish: current marketing availability, therapeutic equivalence, safety, or official approval status. Check an up-to-date product label or a pharmacist for product-specific questions.
Active ingredient record
RxNorm terminologyNavigate from this strength-specific concept to its ingredient identity. An exact name match is a terminology association, not evidence of clinical equivalence or treatment suitability.
Related drug records
RxNorm name matchesThese are other published drug concepts with matching brand or formulation names. They are not necessarily equivalent medicines.
Molecular structure
Active ingredient: meclizine hydrochloride
Active ingredients and chemical structures
RxNorm ingredient relationships. Structures are retrieved by PubChem compound identifier when available. An ingredient can have both a base and a precise salt concept.
Conditions being studied
Drug identity and terminology: RxNorm. Trial relationships: ClinicalTrials.gov.